Skip to main content

Important Safety Information

Peptide therapy safety information

Please read this information carefully before starting any peptide therapy. This page is for educational purposes only and is not a substitute for the guidance of a licensed healthcare provider. Every PeRx prescription is reviewed and approved by a U.S.-licensed provider based on your intake.

General safety

The following applies to all PeRx peptide therapies. Treatment-specific information is listed below.

Warnings

  • Compounded medications are not FDA-approved for safety, effectiveness, or manufacturing quality.
  • Do not use if you are pregnant, planning to become pregnant, or breastfeeding unless directed by your provider.
  • Disclose all medications, supplements, and medical conditions during your assessment — including a personal or family history of cancer, blood clots, or upcoming surgery.
  • Stop use and contact your provider or seek emergency care for signs of a serious allergic reaction (rash, hives, swelling of the face/lips/tongue, trouble breathing).

Common side effects

  • Injection-site redness, soreness, swelling, or bruising
  • Mild headache, lightheadedness, or fatigue in the first days
  • Temporary nausea or flushing

Storage

PeRx peptides ship fully reconstituted and ready to use. Store refrigerated at 36–46°F (2–8°C). Do not freeze. Keep upright and protected from light. Discard per the beyond-use date provided by the pharmacy.

Recovery

BPC-157 — Important Safety Information

The Body Protection Compound

Indication

Accelerates soft tissue repair, gut healing, and full-body recovery from injury.

Dosage & administration

Dosage
250-500mcg daily, duration varies by condition
Administration
Subcutaneous injection near injury site or systemically
Vial
3mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well-tolerated
  • May cause temporary injection site reactions
  • Should only be used under licensed provider supervision
  • Requires medical evaluation and prescription
  • Do not use if you have a known hypersensitivity to BPC-157 or any of its ingredients.
  • Disclose all current medications and medical conditions before starting BPC-157.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Recovery

BPC/TB-500 — Important Safety Information

The Ultimate Recovery Combo

Indication

Dual-action recovery blend combining targeted repair with systemic anti-inflammation.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection daily
Administration
Subcutaneous injection
Vial
3mg/mL (BPC-157) + 5mg/mL (TB-500), 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Not for use with active cancer
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to BPC/TB-500 or any of its ingredients.
  • Disclose all current medications and medical conditions before starting BPC/TB-500.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Growth Hormone

CJC-1295/Ipamorelin — Important Safety Information

Sustained Growth Hormone Release

Indication

Gold-standard GH combo for synergistic fat loss, muscle gain, and deeper sleep.

Dosage & administration

Dosage
CJC-1295 1-2mg + Ipamorelin 200-300mcg subcutaneously before bed
Administration
Subcutaneous injection, typically in the evening
Vial
1.2mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • May cause temporary water retention
  • Possible injection site reactions
  • Should not be used with active cancer
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to CJC-1295/Ipamorelin or any of its ingredients.
  • Disclose all current medications and medical conditions before starting CJC-1295/Ipamorelin.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Growth Hormone

Sermorelin — Important Safety Information

The Growth Hormone Optimizer

Indication

Stimulates natural growth hormone production for better sleep, body composition, and recovery.

Dosage & administration

Dosage
200-300mcg subcutaneously before bed, 5-6 days per week
Administration
Subcutaneous injection, typically administered at bedtime
Vial
2.5mg/mL, 6mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well-tolerated with minimal side effects
  • May cause temporary injection site reactions
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision and monitoring
  • Do not use if you have a known hypersensitivity to Sermorelin or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Sermorelin.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Growth Hormone

Tesamorelin — Important Safety Information

Metabolic Optimization Peptide

Indication

Targets visceral fat reduction through natural growth hormone stimulation.

Dosage & administration

Dosage
2mg subcutaneously daily
Administration
Subcutaneous injection, typically administered in the morning
Vial
2mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well-tolerated with minimal side effects
  • May cause temporary injection site reactions
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision and monitoring
  • Do not use if you have a known hypersensitivity to Tesamorelin or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Tesamorelin.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Growth Hormone

Tesamorelin/Ipamorelin — Important Safety Information

Advanced Metabolic & GH Combo

Indication

Dual-pathway GH combo targeting visceral fat and lean body composition.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection daily
Administration
Subcutaneous injection
Vial
2mg/mL (Tesamorelin) + 1mg/mL (Ipamorelin), 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Should not be used with active cancer
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Tesamorelin/Ipamorelin or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Tesamorelin/Ipamorelin.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Energy

AOD 9604 — Important Safety Information

Pure Fat Burning Peptide

Indication

A growth hormone fragment engineered specifically for targeted fat metabolism.

Dosage & administration

Dosage
250-500mcg daily
Administration
Subcutaneous injection, typically morning on empty stomach
Vial
3mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Should not be used during pregnancy
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to AOD 9604 or any of its ingredients.
  • Disclose all current medications and medical conditions before starting AOD 9604.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Energy

AOD 9604/MOTS-C — Important Safety Information

Fat Burning + Metabolic Reset

Indication

Dual-action combo for targeted fat burning and cellular metabolic optimization.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection
Administration
Subcutaneous injection
Vial
3mg/mL (AOD 9604) + 5mg/mL (MOTS-C), 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Monitor blood glucose in diabetic patients
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to AOD 9604/MOTS-C or any of its ingredients.
  • Disclose all current medications and medical conditions before starting AOD 9604/MOTS-C.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Energy

MOTS-C — Important Safety Information

The Mitochondrial Peptide

Indication

An exercise mimetic that boosts metabolism, insulin sensitivity, and cellular energy.

Dosage & administration

Dosage
5-10mg subcutaneously 3-5 times weekly
Administration
Subcutaneous injection
Vial
5mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Monitor blood glucose in diabetic patients
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to MOTS-C or any of its ingredients.
  • Disclose all current medications and medical conditions before starting MOTS-C.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Cognitive

Semax/Selank — Important Safety Information

Cognitive Clarity & Calm Focus

Indication

Dual nootropic blend for calm focus, cognitive enhancement, and anxiety relief.

Dosage & administration

Dosage
250-500mcg subcutaneously, daily
Administration
Subcutaneous injection
Vial
Semax + Selank combo, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible mild injection site reactions
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Semax/Selank or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Semax/Selank.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Cognitive

Pinealon/PE-22-28/Selank — Important Safety Information

Advanced Neuroprotective Blend

Indication

Triple neuroprotective blend for sleep, neuroregeneration, and calm focus.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection
Administration
Subcutaneous injection
Vial
Pinealon + PE-22-28 + Selank combo, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Pinealon/PE-22-28/Selank or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Pinealon/PE-22-28/Selank.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Sleep

DSIP — Important Safety Information

Deep Sleep Peptide

Indication

Targets deep delta-wave sleep for restorative rest without next-day grogginess.

Dosage & administration

Dosage
100-250mcg before bed
Administration
Subcutaneous injection
Vial
1mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible vivid dreams initially
  • May cause temporary drowsiness
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to DSIP or any of its ingredients.
  • Disclose all current medications and medical conditions before starting DSIP.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Anti-Aging

GHK-Cu — Important Safety Information

The Skin Rejuvenation Peptide

Indication

Boosts collagen production and skin regeneration for visible anti-aging results.

Dosage & administration

Dosage
Topical application or subcutaneous injection per provider guidance
Administration
Subcutaneous injection
Vial
3mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Rare skin sensitivity in some individuals
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider supervision for injectable form
  • Do not use if you have a known hypersensitivity to GHK-Cu or any of its ingredients.
  • Disclose all current medications and medical conditions before starting GHK-Cu.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Anti-Aging

GHK-Cu/Epitalon — Important Safety Information

Skin + Cellular Longevity

Indication

Dual-action blend for visible skin rejuvenation and cellular anti-aging.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection
Administration
Subcutaneous injection
Vial
3mg/mL (GHK-Cu) + 5mg/mL (Epitalon), 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible injection site reactions
  • Monitor thyroid function (Epitalon component)
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to GHK-Cu/Epitalon or any of its ingredients.
  • Disclose all current medications and medical conditions before starting GHK-Cu/Epitalon.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Longevity

Epitalon — Important Safety Information

The Longevity Peptide

Indication

Activates telomerase to protect DNA and slow cellular aging at the source.

Dosage & administration

Dosage
5-10mg daily for 10-20 day cycles
Administration
Subcutaneous injection, cycled periodically
Vial
5mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Limited long-term human data
  • Possible injection site reactions
  • Monitor thyroid function
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Epitalon or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Epitalon.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Immune

Thymosin Alpha-1 — Important Safety Information

Immune System Optimizer

Indication

Trains your immune system's T-cells to fight infections and strengthen defenses.

Dosage & administration

Dosage
1.6mg subcutaneously 2-3 times weekly
Administration
Subcutaneous injection
Vial
5mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally very well tolerated
  • Rare injection site reactions
  • Monitor in autoimmune conditions
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Thymosin Alpha-1 or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Thymosin Alpha-1.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Detox

Glutathione — Important Safety Information

The Master Antioxidant

Indication

The body's master antioxidant for detoxification, immune support, and cellular defense.

Dosage & administration

Dosage
200-600mg subcutaneously per provider guidance
Administration
Subcutaneous injection
Vial
200mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally very well tolerated
  • Possible injection site reactions
  • May interact with certain chemotherapy agents
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to Glutathione or any of its ingredients.
  • Disclose all current medications and medical conditions before starting Glutathione.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Sexual Health

PT-141 — Important Safety Information

On-Demand Intimacy Enhancement

Indication

Enhances sexual desire and arousal by working through the nervous system, not vascular mechanics.

Dosage & administration

Dosage
1.75mg subcutaneously 45 minutes before anticipated activity
Administration
Subcutaneous injection, on-demand use
Vial
2mg/mL, 5mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • May cause temporary flushing or nausea
  • Possible mild blood pressure changes
  • Should not be used during pregnancy or breastfeeding
  • Requires licensed provider evaluation and prescription
  • Do not use if you have a known hypersensitivity to PT-141 or any of its ingredients.
  • Disclose all current medications and medical conditions before starting PT-141.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Longevity

NAD+ — Important Safety Information

The Cellular Energy Coenzyme

Indication

Replenishes a vital coenzyme for DNA repair, energy production, and longevity.

Dosage & administration

Dosage
Per provider guidance, subcutaneous injection
Administration
Subcutaneous injection
Vial
100 mg/mL, 10 mL vial

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • May cause mild injection site irritation
  • Should be administered under licensed provider supervision
  • Monitor in patients with active malignancies
  • Do not use if you have a known hypersensitivity to NAD+ or any of its ingredients.
  • Disclose all current medications and medical conditions before starting NAD+.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Recovery

BPC/TB-500 Capsules — Important Safety Information

Oral Recovery Support

Indication

Oral capsule version of the BPC/TB-500 recovery combo for needle-free convenience.

Dosage & administration

Dosage
Per provider guidance, daily oral capsule
Administration
Oral capsule

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible mild GI effects during adjustment
  • Not for use with active cancer
  • Requires licensed provider supervision
  • Do not use if you have a known hypersensitivity to BPC/TB-500 Capsules or any of its ingredients.
  • Disclose all current medications and medical conditions before starting BPC/TB-500 Capsules.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

Recovery

BPC Capsules — Important Safety Information

Oral Gut & Recovery Support

Indication

Oral BPC-157 capsules for gut healing and needle-free recovery support.

Dosage & administration

Dosage
Per provider guidance, daily oral capsule
Administration
Oral capsule

Your exact dose, frequency, and protocol length will be set by your licensed provider based on your intake.

Warnings & precautions

  • Generally well tolerated
  • Possible mild GI effects during adjustment
  • Should only be used under licensed provider supervision
  • Requires medical evaluation and prescription
  • Do not use if you have a known hypersensitivity to BPC Capsules or any of its ingredients.
  • Disclose all current medications and medical conditions before starting BPC Capsules.
  • Stop use and contact your provider if you experience signs of a serious allergic reaction.

The statements on this page have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved. Always discuss potential risks and benefits with your licensed provider.